股本结构
单位：万股
| 公告日期 | 2023-03-30 | 2023-03-30 | 2022-11-14 | 2022-08-11 | 2022-06-13 | 2022-06-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2801.54 | 2472.23 | 2446.22 | 2128.16 | 2446.22 | 1920.09 |
| 普通股本 | 2801.54 | 2472.23 | 2446.22 | 2128.16 | 2446.22 | 1920.09 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-03-16 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-06-13 | 2022-05-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-03-30 | 2801.54 | 未披露 | 定期报告 | 2023-03-16 |
| 2023-03-30 | 2472.23 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock and pre-funded warrants issued pursuant to the June 2022 registered direct offering, net
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
Exercise of pre-funded warrants related to the June 2022 registered direct offering
|
2022-12-31 |
| 2022-11-14 | 2446.22 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants related to the June 2022 registered direct offering
|
2022-09-30 |
| 2022-08-11 | 2128.16 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Common stock and pre-funded warrants issued pursuant to the June 2022 registered direct offering, net
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
|
2022-06-30 |
| 2022-06-13 | 2446.22 | 未披露 |
更多>>
1.Common stock offered by 2,080,696 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 19,201,867 shares of common stock issued, of which 950 shares are held as treasury shares, as of May 31, 2022
|
2022-06-13 |
| 2022-06-10 | 1920.09 | 未披露 | 定期报告 | 2022-05-31 |
| 2022-05-16 | 1917.26 | 未披露 | 定期报告 | 2022-05-09 |
| 2022-04-27 | 1914.66 | 未披露 | 定期报告 | 2022-04-08 |
| 2022-05-16 | 1898.01 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
|
2022-03-31 |
| 2022-02-18 | 1881.59 | 未披露 |
更多>>
From December 31, 2020 to November 3, 2021
Extinguishment of fractional shares resulting from reverse stock split
Common stock issued pursuant to public offering, net
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreements
Exercise of stock options
|
2021-11-03 |
| 2021-11-10 | 1881.51 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
|
2021-09-30 |
| 2021-08-12 | 1881.32 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-12 | 1881.17 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Common stock issued pursuant to public offering, net
Exercise of common stock warrants
Exercise of stock options
Extinguishment of fractional shares resulting from reverse stock split
|
2021-06-30 |
| 2021-06-21 | 1880.70 | 未披露 |
更多>>
1.Common stock offered 3,636,364 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 15,170,678 shares of common stock outstanding as of May 31, 2021.
|
2021-06-21 |
| 2021-06-16 | 1517.07 | 未披露 | 定期报告 | 2021-05-31 |
| 2021-05-25 | 1517.07 | 未披露 |
更多>>
Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has filed a Certificate of Amendment to the Restated Certificate of Incorporation of the Company to implement a one-for-ten reverse split of its issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on May 25, 2021, and the Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on May 26, 2021.
|
2021-05-26 |
| 2021-05-11 | 15170.72 | 未披露 | 定期报告 | 2021-05-04 |
| 2021-05-11 | 15165.32 | 未披露 |
更多>>
From December 31, 2020 to March 10, 2021
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreement
Exercise of stock options
|
2021-03-10 |
| 2021-03-22 | 15080.32 | 未披露 | 定期报告 | 2021-03-02 |
| 2021-02-24 | 15079.12 | 未披露 | 定期报告 | 2021-02-10 |
| 2021-02-24 | 14570.01 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Common stock and pre-funded warrants issued pursuant to public offering, net
Exercise of pre-funded warrants related to public offering
Common stock and pre-funded warrants issued pursuant to registered direct offering, net
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Exercise of stock options
Common stock issued pursuant to common stock purchase agreements
|
2020-12-31 |
| 2020-10-30 | 14151.38 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of common stock warrants
Exercise of stock options
Common stock issued pursuant to common stock purchase agreement
|
2020-09-30 |
| 2020-08-14 | 13746.84 | 未披露 | 定期报告 | 2020-08-10 |
| 2020-07-23 | 12723.18 | 未披露 | 定期报告 | 2020-07-21 |
| 2020-08-14 | 11942.20 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreements
|
2020-06-30 |
| 2020-06-18 | 7933.71 | 未披露 | 定期报告 | 2020-06-11 |
| 2020-05-20 | 7547.14 | 未披露 | 定期报告 | 2020-05-14 |
| 2020-05-20 | 7201.91 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Common stock and pre-funded warrants issued pursuant to public offering, net
Exercise of pre-funded warrants related to public offering
Common stock and pre-funded warrants issued pursuant to registered direct offering, net
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreement
|
2020-03-31 |
| 2020-03-26 | 7541.64 | 未披露 |
更多>>
On March 24, 2020, Novan, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering priced at the market, an aggregate of 18,604,652 shares of the Company’s common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof). The offering closed on March 26, 2020.
|
2020-03-26 |
| 2020-03-25 | 5681.17 | 未披露 | 定期报告 | 2020-03-23 |
| 2020-03-03 | 4851.81 | 未披露 |
更多>>
On February 27, 2020, Novan, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with H.C. Wainwright & Co., LLC (the “Underwriter”), relating to the offering, issuance and sale of 18,333,334 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying common warrants to purchase up to an aggregate of 18,333,334 shares of common stock. The offering closed on March 3, 2020.
|
2020-03-03 |
| 2020-02-24 | 2743.48 | 未披露 | 定期报告 | 2020-02-03 |
| 2020-02-24 | 2673.48 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Exercise of stock options
Common stock issued pursuant to common stock purchase agreement
|
2019-12-31 |
| 2019-11-12 | 2671.54 | 未披露 | 定期报告 | 2019-11-06 |
| 2019-11-12 | 2651.54 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Common stock issued pursuant to common stock purchase agreement
|
2019-09-30 |
| 2019-05-15 | 2606.97 | 未披露 |
更多>>
From December 31, 2018 to March 31, 2019
Exercise of stock options
|
2019-03-31 |
| 2019-03-27 | 2606.97 | 未披露 | 定期报告 | 2019-03-19 |
| 2019-03-27 | 2606.62 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
|
2018-12-31 |
| 2018-11-05 | 2605.67 | 未披露 | 定期报告 | 2018-11-01 |
| 2018-11-05 | 2605.46 | 未披露 |
更多>>
From December 31, 2017 to September 30, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
|
2018-09-30 |
| 2018-08-08 | 2604.04 | 未披露 |
更多>>
From December 31, 2017 to June 30, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
|
2018-06-30 |
| 2018-05-15 | 2603.87 | 未披露 |
更多>>
From December 31, 2017 to March 31, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
|
2018-03-31 |
| 2018-03-27 | 2603.87 | 未披露 | 定期报告 | 2018-03-23 |
| 2018-03-27 | 1600.54 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Exercise of stock options
|
2017-12-31 |
| 2017-11-09 | 1599.07 | 未披露 | 定期报告 | 2017-11-07 |
| 2017-11-09 | 1598.94 | 未披露 |
更多>>
From December 31,2016 To September 30, 2017
Exercise of stock options
|
2017-09-30 |
| 2017-08-11 | 1598.41 | 未披露 | 定期报告 | 2017-08-10 |
| 2017-08-11 | 1598.16 | 未披露 |
更多>>
From December 31, 2016 to June 30, 2017
Exercise of stock options
|
2017-06-30 |
| 2017-05-12 | 1596.95 | 未披露 |
更多>>
From December 31, 2016 to March 31, 2017
Exercise of stock options
|
2017-03-31 |
| 2017-03-20 | 1596.95 | 未披露 | 定期报告 | 2017-03-17 |
| 2017-03-20 | 1594.00 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Automatic conversion to common stock
Exercise of stock options
Repurchase of treasury stock
Common stock issued through initial public offering, net of underwriting discounts,commissions and offering costs
|
2016-12-31 |
| 2016-11-14 | 1593.87 | 未披露 |
更多>>
From December 31, 2015 to September 30, 2016
Exercise of stock options
Common stock repurchase
Conversion of preferred stock
Conversion of non-voting common stock
Common stock issued through IPO
|
2016-09-30 |
| 2016-09-22 | 1532.37 | 未披露 | 定期报告 | 2016-09-22 |
| 2016-09-22 | 1532.37 | 未披露 |
更多>>
a 1-for-1.2 reverse stock split of our outstanding shares of common stock and a proportional adjustment to the existing conversion ratio of each series of convertible preferred stock, effective September 7, 2016
|
2016-09-21 |
| 2016-09-08 | 244.74 | 1053.17 |
更多>>
From December 31, 2015 to June 30, 2016
Exercise of stock options (unaudited)
Net loss (unaudited)
Common stock repurchase (unaudited)
|
2016-06-30 |
From December 31, 2021 to December 31, 2022
Common stock and pre-funded warrants issued pursuant to the June 2022 registered direct offering, net
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
Exercise of pre-funded warrants related to the June 2022 registered direct offering
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants related to the June 2022 registered direct offering
From March 31, 2022 to June 30, 2022
Common stock and pre-funded warrants issued pursuant to the June 2022 registered direct offering, net
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
1.Common stock offered by 2,080,696 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 19,201,867 shares of common stock issued, of which 950 shares are held as treasury shares, as of May 31, 2022
From December 31, 2021 to March 31, 2022
Common stock issued pursuant to equity distribution agreement (at-the-market facility)
From December 31, 2020 to November 3, 2021
Extinguishment of fractional shares resulting from reverse stock split
Common stock issued pursuant to public offering, net
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreements
Exercise of stock options
From June 30, 2021 to September 30, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Common stock issued pursuant to public offering, net
Exercise of common stock warrants
Exercise of stock options
Extinguishment of fractional shares resulting from reverse stock split
1.Common stock offered 3,636,364 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 15,170,678 shares of common stock outstanding as of May 31, 2021.
Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has filed a Certificate of Amendment to the Restated Certificate of Incorporation of the Company to implement a one-for-ten reverse split of its issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on May 25, 2021, and the Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on May 26, 2021.
From December 31, 2020 to March 10, 2021
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreement
Exercise of stock options
From December 31, 2019 to December 31, 2020
Common stock and pre-funded warrants issued pursuant to public offering, net
Exercise of pre-funded warrants related to public offering
Common stock and pre-funded warrants issued pursuant to registered direct offering, net
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Exercise of stock options
Common stock issued pursuant to common stock purchase agreements
From June 30, 2020 to September 30, 2020
Exercise of common stock warrants
Exercise of stock options
Common stock issued pursuant to common stock purchase agreement
From March 31, 2020 to June 30, 2020
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreements
From December 31, 2019 to March 31, 2020
Common stock and pre-funded warrants issued pursuant to public offering, net
Exercise of pre-funded warrants related to public offering
Common stock and pre-funded warrants issued pursuant to registered direct offering, net
Exercise of pre-funded warrants related to registered direct offering
Exercise of common stock warrants
Common stock issued pursuant to common stock purchase agreement
On March 24, 2020, Novan, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering priced at the market, an aggregate of 18,604,652 shares of the Company’s common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof). The offering closed on March 26, 2020.
On February 27, 2020, Novan, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with H.C. Wainwright & Co., LLC (the “Underwriter”), relating to the offering, issuance and sale of 18,333,334 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying common warrants to purchase up to an aggregate of 18,333,334 shares of common stock. The offering closed on March 3, 2020.
From December 31, 2018 to December 31, 2019
Exercise of stock options
Common stock issued pursuant to common stock purchase agreement
from June 30, 2019 to September 30, 2019
Common stock issued pursuant to common stock purchase agreement
From December 31, 2018 to March 31, 2019
Exercise of stock options
From December 31, 2017 to December 31, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
From December 31, 2017 to September 30, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
From December 31, 2017 to June 30, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
From December 31, 2017 to March 31, 2018
Common stock issued in January 2018 Offering, net of underwriting discounts, commissions and offering costs
Exercise of stock options
from December 31, 2016 to December 31, 2017
Exercise of stock options
From December 31,2016 To September 30, 2017
Exercise of stock options
From December 31, 2016 to June 30, 2017
Exercise of stock options
From December 31, 2016 to March 31, 2017
Exercise of stock options
From December 31, 2015 to December 31, 2016
Automatic conversion to common stock
Exercise of stock options
Repurchase of treasury stock
Common stock issued through initial public offering, net of underwriting discounts,commissions and offering costs
From December 31, 2015 to September 30, 2016
Exercise of stock options
Common stock repurchase
Conversion of preferred stock
Conversion of non-voting common stock
Common stock issued through IPO
a 1-for-1.2 reverse stock split of our outstanding shares of common stock and a proportional adjustment to the existing conversion ratio of each series of convertible preferred stock, effective September 7, 2016
From December 31, 2015 to June 30, 2016
Exercise of stock options (unaudited)
Net loss (unaudited)
Common stock repurchase (unaudited)